Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chickenpox (Varicella Zoster Infection) Clinical Trials

A listing of Chickenpox (Varicella Zoster Infection) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (6) clinical trials

Is your child protected against the Chickenpox? Chickenpox (Varicella Virus) is a highly contagious disease. Viral infections are hard to treat and antibiotics do not work. Vaccines may help prevent your child from getting chickenpox. They may be eligible to join this study. To learn more, call Advanced Clinical Research ...

Phase

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

Study Design single blind study, prospective, parallel group, intent to treat trial Experiment duration: 7 days 2 visits (days 0, and 7) Reduction of symptoms Adverse events evaluation

Phase

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes.Primary infection is manifested as varicella (chickenpox), whereas reactivation of latent VZV results in a localized eruption known as herpes zoster. More than 99.6% of people 40 years of age orolder had evidence of previous VZV infection. This study ...

Phase

Tzanck Smear With Methylene Blue Stain for Herpes

A smear from the lesional skin of the patients suspected having Herpes simplex, Herpes zoster and Varicella zoster skin infections will be collected (in a clinical routine setting). The specimen will be stained with methylene blue in addition to the Giemsa stain. Polymerase chain reaction study for herpes antigen will ...

Phase

A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

This is a multicenter, randomized, double-blind, parallel-group, active controlled comparative study of the safety and efficacy of 2 dosing regimens of FV-100 versus valacyclovir administered for 7 days in subjects with uncomplicated AHZ(acute herpes zoster). Subjects diagnosed with uncomplicated AHZ within 72 hours of lesion appearance and worst pain of ...

Phase

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Following the initial approval of the GlaxoSmithKline (GSK) Biologicals' HZ/su vaccine, the protocol was amended to indicate that the trademark is Shingrix. In addition, the term "candidate" vaccine has been replaced by "study" vaccine throughout the protocol.

Phase